LENZ Therapeutics, Arrotex Ink Commercialization Deal for VIZZ in Australia and New Zealand
SAN DIEGO and MELBOURNE, Australia—LENZ Therapeutics, Inc., (Nasdaq: LENZ) a pharmaceutical company focused on commercializing VIZZ (aceclidine ophthalmic solution) 1.44%, and Arrotex Pharmaceuticals Pty Ltd. have announced an…
